Purchase Order 75N92E23P00214

Award Date 8/1/23
Potential Completion Date 10/1/23
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Woburn, MA 01801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic research equipment and technologies. The $18,835.00 contract is for the delivery of 8 AFA-TUBE TPX STRIP (12) model 520292 devices, which are used in Covaris' adaptive focused acoustics (AFA) sample preparation systems. This award has no set-aside designation. Covaris has...
Covaris, Inc. was awarded a $21,200 purchase order by the Department of Health and Human Services' National Institutes of Health's National Human Genome Research Institute to provide a one-year service plan for a LE220 instrument located in Woburn, Massachusetts. The service plan, valued at $21,200, covers the period of July 1, 2023 through July 1, 2024 and includes quarterly payments for maintenance and support of the LE220 with serial number 3388. No subcontractors or set aside designations...
Covaris, Inc. has been awarded a $16,400 firm fixed-price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide a one-year service plan for equipment serial number 7586. The service plan, covering the period from December 2023 through December 2024, includes quarterly payments for maintenance and support of the equipment located in Woburn, Massachusetts. No set-aside designation or subcontractors were indicated. This support contract will...
This is a $52,055 firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of genomic research equipment. The contract is for the delivery of Covaris' ultrasonicator instruments, accessories, and related maintenance services to support advanced DNA and RNA sample preparation for NIH's scientific initiatives. Covaris has previously received other direct federal...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases awarded a $101,960.50 firm fixed-price purchase order to Covaris, Inc., a for-profit limited liability company, for the delivery of an R230 Focused-Ultrasonicator R-Series Instrument. This award was not set aside for any specific business category. The instrument is to be delivered to a location in Woburn, Massachusetts by January 31, 2023. Covaris...
This firm-fixed-price Purchase Order (PO) contract was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of genomic research equipment and accessories. The purpose of this $16,900 PO is to purchase a one-year service and maintenance plan for Covaris' R230 Ultrasonicator device, which is used in advanced biomolecule fragmentation and sample preparation applications. The contract has...
This firm-fixed-price purchase order contract was awarded to Covaris, LLC, a for-profit manufacturer of advanced genomics tools and technologies, by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $28,185.00, is for the upgrade of ultrasonicator systems used to support NIAID's genomic research initiatives. Covaris, which has extensive experience providing equipment and maintenance services to...
This firm-fixed-price purchase order valued at $4,500 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic sample preparation instruments and accessories. The contract, which had no set-aside designation, was for the delivery of Covaris' ME220, M220, and LE220-plus focused-ultrasonicator systems and related maintenance services to support genomic...
This is a $47,300.00 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic research equipment and accessories. The contract is for the delivery of Covaris' desktop focused-ultrasonicator instruments, such as the ME220, M220, and LE220-plus models, as well as related maintenance services. This award does not have...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic research instrumentation. The $136,470.00 firm-fixed-price purchase order is for the upgrade and expansion of an existing ultrasonicator system. Covaris, LLC has previously received multiple awards from NIH and other federal agencies for the supply of ultrasonicator instruments,...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $19,474 purchase order to Covaris, Inc. Covaris LLC Division of Woburn, Massachusetts. This firm fixed price contract is to provide 01-96 AFA-TUBE TPX PLATE products and services from August 1, 2023 through October 1, 2023 in support of the agency's genomic research initiatives. As the prime contractor, Covaris will deliver the requested items to aid the National Human Genome Research Institute in achieving its mission to drive advances in genomic science that can lead to medical breakthroughs and improve health.

Generated 12/17/23, 8:45 AM